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| INTRODUCTION
Cancer is one of the leading causes of death worldwide, resulting in 8.2 million deaths annually. 1 Treatments for cancer include surgery, radiation therapy, chemotherapy, and targeted therapies. Surgery is often the cornerstone in the treatment of solid cancers in the abdominal cavity. Especially during oncologic surgery, it is pivotal to remove as much tumor as possible and simultaneously to prevent unnecessary damage to surrounding healthy tissue. Despite that the quality of preoperative imaging modalities, such as MRI and CT, has been improved during the last decades, intraoperative navigation using CT or MRI is only performed in specialized hospitals, mostly confined to the field of neurosurgery, due to the complexity, high costs, tissue deformation, and long acquisition times. 2 Today, for intraoperative navigation, the surgeon has to rely in the majority of the cases only on visual and tactile feedback to distinguish between different kind of tissue structures. Additionally, (laparoscopic)
intraoperative ultrasound or sometimes a gamma probe can be used during oncologic surgery. However, this is not always sufficient. Tumor-positive (R1 or R2) resection margins in colorectal cancer, for example, occur in approximately 10% of the operated patients. 3, 4 Together with the increasing rate of minimal invasive (laparoscopic and robotic) surgery and therefore the lack of tactile feedback, there is a demand of improving visibility of different kind of tissue types, especially for distinguishing malignant and benign structures.
In the past years, new intraoperative imaging systems that exploit the near-infrared (NIR) light spectrum, have been evaluated (pre) clinically for different applications. [5] [6] [7] [8] For intraoperative purposes, NIR light (700-900 nm) is more advantageous than visible light due to its capability to penetrate deeper into tissue, up to 10 mm. In addition, in the NIR spectrum tissue exhibits almost no autofluorescence. NIR fluorescent contrast agents lead therefore to maximized signal-tobackground ratios and enhance the contrast of different tissue types. 9, 10 NIR fluorescence imaging requires a NIR fluorescent agent (ie, fluorophore) combined with an imaging system that is able to both excite and detect the fluorophore. The fluorescence signal can be visualized after milliseconds, which is advantageous above other emerging imaging techniques, such as Raman spectroscopy or Optical
Coherence Tomography, which require more time to visualize the same field of view. clinically used as a fluorophore, especially in the field of neurosurgery field. However, this dye is fluorescent at 510 nm, which is outside the NIR spectrum. 12 Consequently, the penetration capacity of 5-ALA is negligible. ICG and MB are nonspecific contrast agents in the near-infrared region and they do not bind to tumor ligands. ICG has a half-time of 150-180 s and is solely cleared by the liver. 13 Its excitation peaks around 800 nm. ICG is very safe; adverse events are reported in less than 1 in 40 000 patients and mostly comprise hypersensitivity reactions. 14 MB in low doses (<2 mg/kg) is safe, however it can induce severe adverse effects such as arrhythmias, coronary vasoconstriction, and hemolytic anemia in patients with renal insufficiency or after administration of higher doses. 15 
| METHODS
We searched in PubMed for in human (in vivo) trials using ICG and MB in NIR fluorescence guided abdominal surgery, published before January 2018. The search was based on the following search items: "Indocyanine green" or "ICG," "Methylene Blue" or "MB,"
"Near-infrared" or "NIR," and "Fluorescence" or "fluorescent." More specific search terms were added per application (SLN mapping, tumor detection, tissue perfusion, detection of vital structures).
Only articles written in English were included. Case reports and (systematic) reviews were excluded from the analysis. After selection of relevant articles, clinically relevant information focussing on how to perform NIR fluorescence imaging in daily practice was extracted from the articles to set-up a review. In this article, the different applications of NIR fluorescence in abdominal surgery, SLN mapping, tumor detection, visualization of vital structures and tissue perfusion, are discussed separately.
| RESULTS
Our search revealed a total of 891 articles, which are reported in a flow diagram ( Figure 1 ). After exclusion of 720 articles, who did not meet our eligibility criteria, a total of 171 original articles remained, which formed the basis of this review.
| SENTINEL LYMPH NODE MAPPING
Sentinel lymph node mapping is only part of standard care in melanoma and breast cancer. 16, 17 Current standard-of-care is a combination of blue dye and gamma probe for Technetium-99m (Tc-99m) detection, which has certain disadvantages. Blue dye has no penetration capacity whatsoever and a gamma probe does not allow visual identification.
SLN mapping is not part of standard clinical care in abdominal oncological surgery. 18, 19 . Today, NIR fluorescence imaging of SLN(s) as a new and additional modality was evaluated for SLN mapping in malignancies of the oesophagus, stomach, colon, bladder, prostate, cervix, endometrium, and ovarium.
| Clinical applications

| Esophageal cancer
Esophageal cancer is a disease with a dismal prognosis, showing an overall 5-year survival rate around 14%. 20 Extensive lymphadenectomy improves the prognosis, especially at early stages. [21] [22] [23] To visualize the sentinel lymph nodes, ICG was evaluated as a NIR fluorescent marker in three clinical studies. All studies were feasibility studies and therefore using a small study population:
1-20 patients. [24] [25] [26] Ninety-five percent of the sentinel lymph nodes could be detected in the cohort of 20 patients, as shown by Yuasa et al. 25 However, further research is necessary before introduction into clinical practice.
ICG during NIR fluorescence imaging during laparoscopic or open gastric surgery. [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] The SLN identification rates ranges from 90% to 100%, however it decreases to 0% for T4 tumors. 35 It also has to be mentioned that most studies did not include these higher stages in their study, which could explain the high resection rates. In Japan and 
| Bladder cancer
A cystectomy with pelvic lymphadenectomy is the treatment of choice for patients with bladder cancer. However, accurate intraoperative detection of SLNs is difficult and lacks sensitivity. 47 Moreover, there is a great inter-patient variability in lymph drainage patterns, which makes the location of the SLN unpredictable. Recently, NIR fluorescence imaging using ICG could detect a sentinel lymph node in at least 90%, which indicated that this technique could contribute to improved intraoperative staging of bladder cancer.
48-50
| Prostate cancer
Prostate cancer is one of the most common cancers in men and treatment consists of diverse interventions, including surgical resection. 51 (Extended) lymph node dissection is sometimes performed during radical prostatectomy, depending on the preoperative risk assessment. 52, 53 Ten studies evaluated the use of ICG during prostatectomy, which showed a high detection rate of SLNs, however due to the low prevalence of SLN metastases a low positive predictive value was found. [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] This supports the findings that NIR fluorescence imaging could be useful in high risk groups.
| Cervical cancer
Early stage cervical cancer, which is often detected by screening, is normally treated with radical hysterectomy and pelvic lymph node dissection. 65 Lymph node status is one of the independent prognostic factors for the patient's survival. 66 However Laios et al 69 showed the lowest detection rate (68%), which was probably caused by the learning process as visualized by a learning curve. Rossi et al 87 showed that cervical stromal injection of ICG is preferable over hysteroscopic endometrial injection for SLN detection, as illustrated by the significant difference in detection rates (82% vs 33% respectively, P = 0.027). 87 These results indicate that SLN mapping with NIR fluorescence imaging is feasible and may be worth considering for use in clinical practice.
| Ovarian cancer
One study evaluated the implementation of NIR fluorescence imaging of SLNs during laparoscopic surgery in seven patients with early-stage ovarian cancer. 98 In all patients, at least one SLN was detected after intraoperatively injection with ICG in both sides of the proper ovarian and suspensory ligament. Nevertheless, more studies have to be performed to determine the added value of fluorescence imaging for intraoperative lymph node staging, which is essential before implementation into clinical practice.
| Summary of findings
Sentinel lymph node mapping using ICG has been evaluated for several applications in abdominal surgery (gastroenterology, urology, and gynecology) with different imaging systems. [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [39] [40] [41] [42] [43] [44] [45] [46] [48] [49] [50] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] In these studies a high diversity in doses has been used, varying from 100 μg to 25 mg. In general, based on the evaluated clinical studies a dose of (at least) 2.5 mg is recommended for good visualization of sentinel lymph nodes.
It was shown, that ICG bound to human serum albumin (ICG:HSA)
could also be used for SLN mapping. 26, 79 Moreover, Hachey et al 26 showed that ICG:HSA is preferable above using ICG alone in esophageal cancer, which could probably be explained by the rapid lymphatic clearance and poor retention of ICG alone. However, due to the limited evidence we prefer an injection of ICG alone. As part of standard care, which consists of peritumoral blue dye injection, ICG could also be injected around the tumor. Most of the studies used a four quadrant injection in the submucosa around the tumor. The timing of the injection is also an important issue. One study in gastric cancer prefers injection (endoscopically) 1 day before surgery. 36 For good visibility of the tumor and consequently a good injection place, a minimal-invasive (endoscopic, cystoscopic) approach is recommended, which also prevents damaging of lymphatic vessels. For cervical and endometrial cancer a cervical stromal injection of ICG is preferable above a hysteroscopic injection. 87 As shown in Figure 2 , approximately 15-30 min after injection, the sentinel lymph nodes will be visualized. 33, 39, 43, 50, 62, 89 In the mean-time the surgical procedure can be started, and the surgeon will therefore lose minimal time. After identification of the SLN(s) the additional oncological resection can be performed.
| How to use it
Taken together, optimal use of ICG for SLN mapping could be achieved by peritumorally injection of 2.5 mg ICG. Intraoperative injection, just after applying anesthesia, in a minimal invasive manner seems optimal.
The SLNs could be visualized 15-30 min after injection (Table 1) .
| TUMOR IMAGING
ICG has been used as a contrast agent for intraoperative detection of diverse tumor types, which is based on two characteristics of ICG:
hepatic clearance and the enhanced permeability and retention (EPR) effect. Solid tumors (other than hepatobiliary tract) could be visualized by the EPR effect, which is based on the visualization with ICG of the increased permeability and reduced drainage in tumor tissue after tumor-induced angiogenesis. signal rather than a dark center. In a retrospective cohort study in our institute it was shown that NIR fluorescence imaging of colorectal liver metastases was able to identify more and smaller tumors, resulting in reduced recurrences in a subset of patients. 103 Twenty-one studies evaluated the use of NIR fluorescence imaging with ICG for liver tumor detection, both primary tumors as metastatic spread of colorectal, uveal, breast, and pancreatic cancer.
101,102,104-122
Summary of findings
To establish the optimal dose and injection time our group performed a comparison study with 10 and 20 mg ICG injection.
However, no significant difference in optimal tumor-to-background contrast between respectively a 24 or 48 h administration and 10 or 20 mg injection was found. 122 Therefore, we recommend a bolus of 10 mg of injected intravenously 24 h before surgery based on clinical and logistical preferences. Tumor tissue compresses small bile ducts and consequently causes local inflammation. In these bile ducts and inflamed liver tissue ICG is retained for some days. Therefore, other groups showed also good results with ICG injection up to 14 days before surgery, although using much higher doses of ICG, up to 0.5 mg/kg. 101, 106, 108, 109, [111] [112] [113] [117] [118] [119] [120] Today, no randomized trial has been performed to compare these high differences in dosing and injection timing. After administering ICG, a fluorescent rim can be identified around tumors during surgery, as illustrated in Figure 3 .
Several studies showed that this technique not only identifies known tumors, but also occult, otherwise undetectable submillimeter tumors. However, only subcapsular lesions up to around 1 cm from the liver surface are expected to be visible, due to the limited penetration depth of NIR fluorescence. 123 Nevertheless, it could therefore be used as a complementary intraoperative tool, as CT/MRI and intraoperative ultrasound still showed relatively high rates of false negatives for superficially located (subcapsular) lesions.
124,125
| Peritoneal metastases
Preoperative detection of peritoneal metastases is often difficult with the current image modalities. 126 Adequate pre-and intra-operative staging is therefore an important issue for offering the best treatment.
In the last years, more evidence is coming up, which showed that hyperthermic intraperitoneal chemotherapy (HIPEC) combined with cytoreductive surgery gave a better survival in patients with limited peritoneal metastases from colorectal or ovarian cancer. 127, 128 Four (pilot) studies evaluated the intraoperative visibility of peritoneal spread in liver, colorectal, and ovarian cancer with NIR fluorescence imaging. [129] [130] [131] [132] All studies showed a good visibility of peritoneal metastases, however in patients with ovarian cancer treated with HIPEC, distinguishing benign scars and malignant lesions was difficult. 131 Moreover, Tummers et al 132 showed a high false positive rate, which could be explained by the EPR effect, which underscores the need for tumor-selective targets. As HCC tissues often retain bile juice productivity even in metastatic sites, fluorescence imaging following preoperative intravenous injection of ICG can also be applied to identification of extrahepatic metastases of HCC.
130
Summary of findings
All studies started with ICG injection 24 h before surgery. Unfortunately, no fluorescence signal was visible during exploration. However, intraoperative injection was feasible and showed good results. Hence, we recommend intravenously injection of ICG after abdominal detection of small peritoneal metastases is hampered in some abdominal regions (such as in the liver and visceral peritoneum).
| Adrenal tumors
Adrenal masses are often resected by performing minimal invasive surgery (laparoscopic or robotic). 134, 135 Identification of the adrenal glands and determining the resection margins could be difficult, especially when it is surrounded by retroperitoneal fat. The added value of NIR fluorescence imaging using ICG during minimal invasive (partial) adrenalectomy has been determined in four studies.
136-139
Based on the difference in perfusion between the adrenals and the surrounding tissues, the adrenal glands and different types of adrenal tumors could be detected. Colvin et al 139 showed that NIR fluorescence imaging was superior and equivalent in 46.5% and 25.6% respectively, to conventional robotic view in determining the borders of the adrenal glands in 40 patients. Other mentioned studies showed similar results in determining the adrenal gland borders, however they were performed in much smaller populations.
Summary of findings
Three out of four studies used a 5 mg dose of ICG, which turned out to be the optimal dose for visibility of the adrenal glands. 136, 138, 139 After exposure of the retroperitoneum and acquiring a good view on the adrenal glands and its surrounding tissue, ICG could be intravenously injected. One minute after injection of ICG, the fluorescence signal could be detected. 139 First of all, the arterial vasculature of the adrenal glands and kidneys became fluorescent. After a few seconds, the fluorescence signal highlights the adrenal parenchyma, however it is slightly less fluorescent as the adjacent kidneys. 138 Adrenocortical tumors could be easily recognized by the hyperfluorescent signal, although medullary tumors (such as pheochromocytomas) were hypofluorescent during NIRF imaging. 138, 139 In the background, the liver could show more intense fluorescence, in case of right adrenal surgery. The optimal tumor-to-background contrast is achieved after 5 min. 139 If the fluorescent signal washes out (>20 min after injection), a new injection of 5 mg ICG could be administered.
| Other solid tumors
ICG has also been evaluated in other solid tumors in the abdominal region, although the added value has not been proven. Our group studied the role of ICG for intraoperative visualization of pancreatic tumors during pancreaticoduodenectomy in eight patients. 140 After injection of ICG, only in one patients a clear tumor-to-pancreas contrast was observed. The use NIR fluorescence imaging during nephrectomy has also been a topic of research, as reviewed by Bjurlin et al. 141 Based on the angiographic properties of ICG, it could play a role in determining vascular clamping during nephrectomy. 
| How to use it
As summarized in Table 1, we recommend 
| VISUALIZATION OF VITAL STRUCTURES
Currently, no good intraoperative imaging techniques are available for both biliary duct and ureter visualization. Intraoperative cholangiography is sometimes used for enhanced bile duct identification. Two disadvantages of this technique are the exposition of radiation to the patients and health care personnel and the chance of causing bile duct injuries by bile duct cannulation. 145, 146 Other techniques such as ureteral stenting is sometimes performed to visualize the ureter.
However, the benefit is currently questionable and it is also associated with a risk of ureteral injury. 147, 148 NIR fluorescence imaging with ICG and MB is used for both biliary and ureter mapping, based on their clearance characteristics. 
Summary of findings
Before starting with NIR fluorescence cholangiography, 5 mg ICG should be prepared according to a recent optimal dose study of our group. 183 Administering ICG directly prior to surgery results in highly fluorescent liver tissue, which may hamper identification of bile ducts. Therefore, ICG has to be injected intravenously 3-7 h before surgery for optimal bile duct to liver contrast, resulting in a better bile duct discrimination. For elective cholecystectomy, which is sometimes part of oncologic surgery (in case of cholangio-or pancreatic-carcinoma), this approach is feasible. Five studies showed that with this dose the cystic duct beginning to became fluorescent around 30 to 40 min after intravenous ICG injection. 158, 159, 169, 170, 176 In general, during cholecystectomy it is important to obtain the critical view of safety: visibility of the cystic duct and cystic artery entering the gallbladder. After preparation of the gallbladder hilum both medially and laterally, critical view could be achieved by retracting the gallbladder caudo-medially and exposing the triangle of Calot (Figure 4) . If the cystic duct was detected, ICG could also be administrated again to visualize the cystic artery. It is important to realize that after a second ICG administration, the liver will become again highly fluorescent. After detection of both the cystic duct and cystic artery, these structures could be transected and the gallbladder could be removed.
| Ureter
Ureter injuries were seen in minority of the cases during colorectal surgery, with a reported incidence varying from 0.15% to 0.66% for open and laparoscopic procedures, respectively. 184 Although the incidence seems low, ureteral injuries are associated with a significant morbidity. The use of intraoperative ureter visualization with NIR fluorescence imaging was evaluated in six studies, of which four studies used ICG and two used MB as contrast agents. [185] [186] [187] [188] [189] [190] ICG was used in three studies during robotic surgery to detect the level of the ureteral stenosis in a population varying from 7 to 25 patients. In these studies ICG was injected both through the ureteral catheter, of which only the tip was inserted into the ureteral orifice, or in the renal pelvis.
Summary of findings
We prefer MB above ICG as a NIR fluorescent contrast agent for detection of the ureter, because MB is cleared via the kidneys and could therefore intravenously injected easily. Verbeek et al 190 showed that in 12 patients both ureters could be detected 10 min after infusion of MB, whereas Al Taher et al 185 
| How to use it
To summarize, ICG could be used for biliary duct imaging, whereas MB is preferable for ureter mapping. Optimal doses and injection times are 5 mg 3-7 h before surgery, and 0.25 mg/kg intraoperatively, respectively (Table 1) .
| TISSUE PERFUSION
Restoring normal functioning and tissue healing after surgical intervention is, among others, critically dependent on tissue perfusion.
Insufficient perfusion with oxygenated blood could result in ischemia and subsequent tissue damage. An important clinical problem is anastomotic leakage, which is one of the most serious complication after gastrointestinal surgery. 191, 192 Large retrospective cohort studies showed leakage rates up to 19% in case of colorectal surgery. 192 Today, surgeons have to evaluate the anastomotic perfusion by inspection, which is a subjective method and difficult to quantify. 193 Different techniques have been used to evaluate the anastomotic perfusion, however none of them are currently common used in clinical practice, due to their disadvantages. 194 Intraoperative evaluation of liver perfusion is also a clinical relevant issue, especially for determining the effect of the resection on the liver function, however currently no good intraoperative tools are available. Some studies suggests the use of contrast enhanced ultrasound, as an additional tool for resection planning. 195, 196 Due to the characteristic of ICG binding to plasma proteins, it will mainly remain intravascular after intravenously injection, which makes it a perfect candidate for perfusion imaging.
| Clinical applications
| Anastomotic bowel perfusion
As the introduction of NIR fluorescence imaging, 11 clinical studies reported the use of ICG as a NIR fluorescent agent in evaluation of the esophagogastric anastomosis. 24, 194, [197] [198] [199] [200] [201] [202] [203] [204] [205] One study compared the anastomotic leakage rate in perfusion detection both with and without the use of ICG fluorescence imaging, which resulted in reducing the rate from 20% to 0%. 205 Twenty-one clinical trials reported the use of ICG as a NIR fluorescence agent with different imaging systems in intraoperative evaluation of colorectal anastomoses. 180, [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] was often injected after anastomotic site selection to evaluate the effect of ICG in selecting the correct anastomotic site. This resulted in the change of surgical plan between 3.7% and 40%. Some studies also evaluated the rate of the AL with using ICG and it was shown in a recent systematic review that the rate of AL decreases from 8.5% to 3.3% in the group which used ICG. 226 On the other hand, a casematched retrospective study in 346 patients did not show a significant decline in AL (7.5% vs 6.4%), although the anastomotic site was changed in 5% of the patients. 
Summary of findings
Based on the above mentioned studies we recommend the following approach. First of all, normal surgical procedure could be started according to standard of care. Before performing the anastomosis, 2.5 mg of ICG dye can be injected intravenously, which is based on the doses used in most of the clinical trials. [197] [198] [199] [200] 202, 203 However, most studies in colorectal surgery used ICG injection doses varying from 0.2 to 0.5 mg/kg. 206, 213, 221, 223, 224 Nevertheless, it was shown that the colorectal anastomotic perfusion could also be visualized by using a much lower and less toxic dose (2.5 mg), which is in concordance with the optimal dose used for evaluation gastroesophageal anastomotic perfusion. 210, 212 Hence, we recommend an intravenously injection of 2.5 mg ICG for both types of anastomoses. Within 60 s the vasculature will be visible and the anastomotic site can be visualized with NIR fluorescence imaging. 209, 210, 212, 215, 223 If the fluorescence signal starts to fade, another bolus of 2.5 mg ICG can be injected to evaluate the perfusion for a second look (>15 min after first injection). If a good perfusion was detected with NIR fluorescence imaging, the procedure could be finished as usual.
| Hepatic perfusion during liver segmentectomy
Due to the complex liver anatomy, liver surgery is only performed in high volume centers. Especially, during oncologic surgery, it is difficult to determine the resection margins and to estimate the remnant liver volume in order to achieve the optimal balance between cancer curability and postoperative hepatic function. The portal and hepatic veins are the important anatomical landmarks used for resection planning. Seven studies evaluated the use of ICG for determining the resection planes during liver surgery. 104, 110, 117, 164, [227] [228] [229] In 89% to 100% of the performed surgeries, the resection lines could be easily visualized. and adrenal tumors using ICG is feasible and could therefore be used as an additional intraoperative image modality until specific tumor targets are available. Today, no evidence is available for intraoperative visualization of nerves, which is important during colorectal surgery, using ICG due to its non-specificity. [230] [231] [232] Therefore, diverse other nerve specific contrast agents are currently being investigated. [233] [234] [235] [236] [237] MB was evaluated for ureter detection, however its clinical use during abdominal surgery, would be limited subject due to higher absorption and more nonspecific background fluorescence. Hence, a specific antibody binding to a fluorophore, ZW800-1, has been evaluated and showed better ureter visibility than MB in preclinically testing. 238 Moreover, it was also described that MB could be useful in abdominal surgery for detection of neuroendocrine tumors. However, the evidence is limited to one preclinical mice study and a case report of a patient with a paraganglioma, and should therefore be further validated in new studies. 239, 240 To improve the tumor visibility during oncologic surgery, (new)
Summary of findings
NIR fluorophores, such as IRDye-800CW, were combined with tumor-specific targets as described by Haque et al. 241 Diverse specific tumor-specific fluorophores have been investigated during the last years, for instance in patients with colorectal cancer (during endoscopy), ovarian cancer, renal cell carcinoma, and peritonitis carcinomatosa. [242] [243] [244] [245] [246] In conclusion, ICG and MB are relatively safe and sensitive nonspecific fluorophores, which have been widely evaluated in NIR fluorescence imaging. In the nearby future, more specific tumor targets will be evaluated and used in clinical practice, which will provide new opportunities in the field of abdominal surgery.
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